296 related articles for article (PubMed ID: 36059045)
1. Cathelicidin-related antimicrobial peptide mediates skeletal muscle degeneration caused by injury and Duchenne muscular dystrophy in mice.
Choi MC; Jo J; Lee M; Park J; Yao TP; Park Y
J Cachexia Sarcopenia Muscle; 2022 Dec; 13(6):3091-3105. PubMed ID: 36059045
[TBL] [Abstract][Full Text] [Related]
2. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
[TBL] [Abstract][Full Text] [Related]
3. Skeletal muscle fibrosis in the mdx/utrn+/- mouse validates its suitability as a murine model of Duchenne muscular dystrophy.
Gutpell KM; Hrinivich WT; Hoffman LM
PLoS One; 2015; 10(1):e0117306. PubMed ID: 25607927
[TBL] [Abstract][Full Text] [Related]
4. Cytoplasmic HDAC4 regulates the membrane repair mechanism in Duchenne muscular dystrophy.
Renzini A; Marroncelli N; Cavioli G; Di Francescantonio S; Forcina L; Lambridis A; Di Giorgio E; Valente S; Mai A; Brancolini C; Giampietri C; Magenta A; De Santa F; Adamo S; Coletti D; Moresi V
J Cachexia Sarcopenia Muscle; 2022 Apr; 13(2):1339-1359. PubMed ID: 35170869
[TBL] [Abstract][Full Text] [Related]
5. SERCA1 overexpression minimizes skeletal muscle damage in dystrophic mouse models.
Mázala DA; Pratt SJP; Chen D; Molkentin JD; Lovering RM; Chin ER
Am J Physiol Cell Physiol; 2015 May; 308(9):C699-709. PubMed ID: 25652448
[TBL] [Abstract][Full Text] [Related]
6. Pannexin 1 dysregulation in Duchenne muscular dystrophy and its exacerbation of dystrophic features in mdx mice.
Freeman E; Langlois S; Leyba MF; Ammar T; Léger Z; McMillan HJ; Renaud JM; Jasmin BJ; Cowan KN
Skelet Muscle; 2024 Apr; 14(1):8. PubMed ID: 38671506
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological Inhibition of PKCθ Counteracts Muscle Disease in a Mouse Model of Duchenne Muscular Dystrophy.
Marrocco V; Fiore P; Benedetti A; Pisu S; Rizzuto E; Musarò A; Madaro L; Lozanoska-Ochser B; Bouché M
EBioMedicine; 2017 Feb; 16():150-161. PubMed ID: 28089792
[TBL] [Abstract][Full Text] [Related]
8. Hypochlorous acid exposure impairs skeletal muscle function and Ca
Lea TA; Panizza PM; Arthur PG; Bakker AJ; Pinniger GJ
J Physiol; 2023 Dec; 601(23):5257-5275. PubMed ID: 37864413
[TBL] [Abstract][Full Text] [Related]
9. RhoA/ROCK2 signalling is enhanced by PDGF-AA in fibro-adipogenic progenitor cells: implications for Duchenne muscular dystrophy.
Fernández-Simón E; Suárez-Calvet X; Carrasco-Rozas A; Piñol-Jurado P; López-Fernández S; Pons G; Bech Serra JJ; de la Torre C; de Luna N; Gallardo E; Díaz-Manera J
J Cachexia Sarcopenia Muscle; 2022 Apr; 13(2):1373-1384. PubMed ID: 35132805
[TBL] [Abstract][Full Text] [Related]
10. Increased plasma lipid levels exacerbate muscle pathology in the mdx mouse model of Duchenne muscular dystrophy.
Milad N; White Z; Tehrani AY; Sellers S; Rossi FMV; Bernatchez P
Skelet Muscle; 2017 Sep; 7(1):19. PubMed ID: 28899419
[TBL] [Abstract][Full Text] [Related]
11. Long-Term Protective Effect of Human Dystrophin Expressing Chimeric (DEC) Cell Therapy on Amelioration of Function of Cardiac, Respiratory and Skeletal Muscles in Duchenne Muscular Dystrophy.
Siemionow M; Langa P; Brodowska S; Kozlowska K; Zalants K; Budzynska K; Heydemann A
Stem Cell Rev Rep; 2022 Dec; 18(8):2872-2892. PubMed ID: 35590083
[TBL] [Abstract][Full Text] [Related]
12. Sarcolipin deletion in mdx mice impairs calcineurin signalling and worsens dystrophic pathology.
Fajardo VA; Chambers PJ; Juracic ES; Rietze BA; Gamu D; Bellissimo C; Kwon F; Quadrilatero J; Russell Tupling A
Hum Mol Genet; 2018 Dec; 27(23):4094-4102. PubMed ID: 30137316
[TBL] [Abstract][Full Text] [Related]
13. Haploinsufficiency of utrophin gene worsens skeletal muscle inflammation and fibrosis in mdx mice.
Zhou L; Rafael-Fortney JA; Huang P; Zhao XS; Cheng G; Zhou X; Kaminski HJ; Liu L; Ransohoff RM
J Neurol Sci; 2008 Jan; 264(1-2):106-11. PubMed ID: 17889902
[TBL] [Abstract][Full Text] [Related]
14. Neopterin/7,8-dihydroneopterin is elevated in Duchenne muscular dystrophy patients and protects mdx skeletal muscle function.
Lindsay A; Schmiechen A; Chamberlain CM; Ervasti JM; Lowe DA
Exp Physiol; 2018 Jul; 103(7):995-1009. PubMed ID: 29791760
[TBL] [Abstract][Full Text] [Related]
15. Assessing the Use of the sGC Stimulator BAY-747, as a Potential Treatment for Duchenne Muscular Dystrophy.
Krishnan SM; Nordlohne J; Dietz L; Vakalopoulos A; Haning P; Hartmann E; Seifert R; Hüser J; Mathar I; Sandner P
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360780
[TBL] [Abstract][Full Text] [Related]
16. The microRNA miR-133b functions to slow Duchenne muscular dystrophy pathogenesis.
Taetzsch T; Shapiro D; Eldosougi R; Myers T; Settlage RE; Valdez G
J Physiol; 2021 Jan; 599(1):171-192. PubMed ID: 32991751
[TBL] [Abstract][Full Text] [Related]
17. Acute AT
Meyers TA; Heitzman JA; Krebsbach AM; Aufdembrink LM; Hughes R; Bartolomucci A; Townsend D
J Mol Cell Cardiol; 2019 Mar; 128():51-61. PubMed ID: 30664850
[TBL] [Abstract][Full Text] [Related]
18. Pre-clinical evaluation of N-acetylcysteine reveals side effects in the mdx mouse model of Duchenne muscular dystrophy.
Pinniger GJ; Terrill JR; Assan EB; Grounds MD; Arthur PG
J Physiol; 2017 Dec; 595(23):7093-7107. PubMed ID: 28887840
[TBL] [Abstract][Full Text] [Related]
19. The location of protein oxidation in dystrophic skeletal muscle from the mdx mouse model of Duchenne muscular dystrophy.
Iwasaki T; Terrill JR; Kawarai K; Miyata Y; Tagami T; Maeda N; Hasegawa Y; Watanabe T; Grounds MD; Arthur PG
Acta Histochem; 2022 Dec; 124(8):151959. PubMed ID: 36270048
[TBL] [Abstract][Full Text] [Related]
20. miR-146a deficiency does not aggravate muscular dystrophy in mdx mice.
Bronisz-Budzyńska I; Chwalenia K; Mucha O; Podkalicka P; Karolina-Bukowska-Strakova ; Józkowicz A; Łoboda A; Kozakowska M; Dulak J
Skelet Muscle; 2019 Aug; 9(1):22. PubMed ID: 31412923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
